In MM cells, CD155 modification by the ubiquitin-like molecule SUMO promotes its intracellular retention resulting in a reduction of CD155 surface expression and an impairment of CD155-related functions including cytotoxic immune cell activation and MM adhesion to bone marrow stromal cells [17,38]. This evidence concerns the gene PVR and Miyoshi myopathy.